Evidence map›Paper›PMID 23270930›Full record

ArticleClinical nephrology2013

Chronic kidney disease at presentation is not an independent risk factor for AIDS-defining events or death in HIV-infected persons.

Tahira P Alves, Pingsheng Wu, T Alp Ikizler, Timothy R Sterling, Samuel E Stinnette, Peter F Rebeiro, Suvro Ghosh, Todd Hulgan

Open access · greenAbstract read
In one paragraph

Article in Clinical nephrology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Tahira P AlvesUniversity of Texas Health Science Center at San Antonio, Department of Medicine, Division of Nephrology, San Antonio, TX 78229, USA. tahira.palmer@yahoo.com
Pingsheng Wu
T Alp Ikizler
Timothy R Sterling
Samuel E Stinnette
Peter F Rebeiro
Suvro Ghosh
Todd Hulgan
The University of Texas Health Science Center at San Antonio · US

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
VIROLOGY COREP30AI054999 · NIAID · VANDERBILT UNIVERSITY · PI KALAMS, SPYROS A · 2003 to 2011
$10.3M
VANDERBILT NEPHROLOGY TRAINING PROGRAMT32DK007569 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HARRIS, RAYMOND C., IKIZLER, TALAT ALP · 1988 to 2024
$5.8M
Mentoring in HIV and Tuberculosis ResearchK24AI065298 · NIAID · VANDERBILT UNIVERSITY · PI STERLING, TIMOTHY R · 2005 to 2014
$1.6M
Nutrition and Metabolism in Dialysis PatientsK24DK062849 · NIDDK · VANDERBILT UNIVERSITY · PI IKIZLER, TALAT ALP · 2003 to 2012
$1.6M
Oxidant Stress and Antioxidants during HIV TherapyK23AT002508 · NCCIH · VANDERBILT UNIVERSITY · PI HULGAN, TODD M · 2004 to 2007
$473k
NCCIH NIH HHS K23 AT002508NCRR NIH HHS 1UL-1RR024975NCRR NIH HHS UL1 RR024975NIAID NIH HHS K24 AI065298NIAID NIH HHS P30 AI054999NIDDK NIH HHS 5 T32 DK007569-17NIDDK NIH HHS K24 DK062849NIDDK NIH HHS K24 DK62849NIDDK NIH HHS T32 DK007569
6 · The paper itself

Abstract

Studies have documented an association between chronic kidney disease (CKD) and increased risk of end stage renal disease, death and comorbidities, including cardiovascular disease and metabolic syndrome, in the general population. However, there is little data on the relationship between CKD and ADE (AIDS defining event), and to our knowledge, no studies have analyzed death as a competing risk for ADE among HIV-infected persons. An observational cohort study was performed to determine the incidence and risks for developing an ADE or death among HIV-infected persons with and without CKD from 1998 - 2005. CKD was defined as an estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73 m2 using the CKDEpidemiology Collaboration (CKD-EPI) equation. Log rank test and Cox regression which determined time to development of ADE and/or death as combined and separate outcomes, and competing risk models for ADE versus mortality, were performed. Among the 2,127 persons that contributed to the 5,824 person years of follow-up: 22% were female, 34% African American, 38% on HAART, and 3% had CKD at baseline. ADE occurred in 227 (11%) persons and there were 80 (4%) deaths. CKD was not significantly associated with ADE/death (HR 1.3, 95% CIs: 0.5, 3.2), ADE (HR 1.0, 95% CIs: 0.4, 3.1), or death (HR 1.6, 95% CIs: 0.4, 3.1). Competing risk analyses confirmed no statistically significant associations between CKD and these outcomes. CKD was uncommon in HIV-infected persons presenting for care in this racially diverse cohort, and was not independently associated with risk of developing an ADE or dying during follow-up.

Indexed as

AdultAnalysis of VarianceAntiretroviral Therapy, Highly ActiveCohort StudiesFemaleHIV InfectionsHumansMaleMiddle AgedRegression AnalysisRenal Insufficiency, ChronicRetrospective StudiesRisk FactorsTennesseeTreatment Outcome

Identifiers

PMID23270930
PMCPMC3726221
OpenAlexW2074929035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.